Maura G, Pittaluga A, Ulivi M, Raiteri M
Istituto di Farmacologia e Farmacognosia, Università di Genova, Italy.
Eur J Pharmacol. 1988 Nov 15;157(1):23-9. doi: 10.1016/0014-2999(88)90466-9.
The effects of various adrenergic agents on the release of endogenous gamma-aminobutyric acid (GABA) and of [3H]GABA were studied in superfused synaptosomal preparations from rat hippocampus. Noradrenaline (NA) enhanced in a concentration-dependent way the release of endogenous GABA but did not affect the release of the radioactive amino acid. The effect of NA was mimicked by the alpha 2-adrenoceptor agonist, clonidine, but not by the alpha 1-agonist, phenylephrine. Accordingly, NA was antagonized by the alpha 2-adrenoceptor antagonist, yohimbine, but not by the alpha 1-antagonist, prazosin. Both (+)-mianserin and (-)-mianserin, used as alpha 2-adrenoceptor blockers, counteracted the NA-evoked release of endogenous GABA. The results suggest that GABA released from hippocampus crude synaptosomes is modulated by alpha 2-adrenoceptors pharmacologically different from the alpha 2-autoreceptors that modulate NA release and previously found to be blocked by (+)-mianserin but not by the (-) enantiomer (Raiteri et al., 1983).
在大鼠海马超融合突触体标本中研究了各种肾上腺素能药物对内源性γ-氨基丁酸(GABA)和[3H]GABA释放的影响。去甲肾上腺素(NA)以浓度依赖性方式增强内源性GABA的释放,但不影响放射性氨基酸的释放。NA的作用可被α2-肾上腺素能受体激动剂可乐定模拟,但不能被α1-激动剂去氧肾上腺素模拟。相应地,NA可被α2-肾上腺素能受体拮抗剂育亨宾拮抗,但不能被α1-拮抗剂哌唑嗪拮抗。用作α2-肾上腺素能受体阻滞剂的(+)-米安色林和(-)-米安色林均可抵消NA诱发的内源性GABA释放。结果表明,海马粗突触体释放的GABA受α2-肾上腺素能受体调节,这些受体在药理学上不同于调节NA释放的α2-自身受体,且先前发现(+)-米安色林可阻断该受体,而(-)对映体则不能(Raiteri等人,1983年)。